| Characteristics | Total () | Survivor () | Nonsurvivor () | |
| Age (month) | 26.2 (8.9, 64) | 26.5 (9.5, 62.6) | 22 (5.8, 67.6) | 0.479 | Gender (male, %) | 505 (61.7) | 454 (63.1) | 51 (51.5) | 0.027 | PRISM III | 7 (7, 10) | 7 (7, 10) | 15 (12, 16) | <0.001 | Complications | | | | | Respiratory failure, (%) | 308 (37.6) | 248 (34.4) | 60 (66.7) | <0.001 | Shock, (%) | 138 (16.8) | 104 (14.4) | 34 (34.3) | <0.001 | Gastrointestinal disorder, (%) | 36 (4.4) | 27 (3.8%) | 9 (9) | 0.015 | Liver injury, (%) | 167 (20.4) | 139 (19.3) | 28 (28.3) | 0.038 | Acute kidney injury, (%) | 40 (4.9) | 31 (4.3) | 9 (9.1) | 0.038 | Heart failure, (%) | 34 (4.2) | 26 (3.6) | 8 (8.1) | 0.037 | Immune disorder, (%) | 61 (7.4) | 55 (7.6) | 6 (6.1) | 0.575 | Brain injury, (%) | 43 (5.3) | 32 (4.4) | 11 (11.1) | 0.005 | Extracorporeal life support | | | | | Artificial respiration, (%) | 306 (37.4) | 233 (32.4) | 73 (73.7) | <0.001 | CRRT, (%) | 88 (10.7) | 61 (8.5) | 27 (27.3) | <0.001 | ECMO, (%) | 7 (0.85) | 4 (0.6) | 3 (3.0) | 0.012 | Length of hospital stay (day) | 13 (8, 21) | 13 (9, 21) | 8 (4, 21) | <0.001 |
|
|